|
Symbol
|
RMACHV | ACKUTQ | ACLATQ | ACRFTQ | RMBDRV | RMBDNV | ADTRTQ | ADZYTQ | RMAV6V |
|---|---|---|---|---|---|---|---|---|---|
| Nom | Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible | Reverse Convertible | Reverse Convertible | Worst of Callable Reverse Convertible | Multi Reverse Convertible | Multi Vonti |
|
Sous-jacent
|
ASML Hldg. N.V. / Novo Nordisk AS (B) / SAP SE | Amgen Inc. / Intuitive Surgical Inc. / Novo Nordisk AS (B) | Amgen Inc. / Intuitive Surgical Inc. / Novo Nordisk AS (B) | Amgen Inc. / Intuitive Surgical Inc. / Novo Nordisk AS (B) | ASML Hldg. N.V. / Novo Nordisk AS (B) | ASML Hldg. N.V. / Novo Nordisk AS (B) | Adidas AG / LVMH Moet Hennessy Louis Vuitton / Novo Nordisk AS (B) | Alcon / Novo Nordisk AS (B) / Roche PS | ASML Hldg. N.V. / Novo Nordisk AS (B) / Oracle Corp. |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
17.08.2026 | 17.03.2027 | 17.03.2027 | 14.04.2027 | 13.08.2027 | 13.08.2027 | 20.08.2029 | 08.09.2026 | 11.10.2028 |
| Ratio | - | - | - | - | - | - | - | - | - |
|
Prix d'exercise
|
757,40 | 418,32 | 384,58 | 303,835 | 217,13 | 217,13 | 192,27 | 288,429 | 188,34 |
| rendement max. p.a. | - | - | - | - | - | - | - | - | - |
| Demande | - | - | - | - | - | - | - | - | - |
| Offre | - | - | - | - | - | - | - | - | - |